Skip to main content
OpenTrials
Completed

NCT Number: NCT04734392

Reducing Pacemaker Implantation After TAVR With Modified Implantation Technique

Hypothesis of the study is that a modified and improved implantation protocol (regarding membranous septum length and implantation depth) will decrease the need for permanent pacemaker stimulation follow TAVR-procedures.

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ulm University

Ulm, 89081, Germany

About this study

Project objectives or hypothesis Hypothesis of the study is that a modified and improved implantation protocol (regarding membranous septum length and implantation depth) will decrease the need for permanent pacemaker stimulation following TAVR-procedures.

Patient profile and sample size The study cohort will comprise of patients referred to transcatheter aortic valve replacement. Patients will be prospectively and consecutively screened and enrolled at a tertiary high-volume center in Germany. TAVR will be performed according to a modified implantation technique regarding membranous septum length. Pacemaker rates will be analyzed and compared to a historical control. Taking into account a contemporary pacemaker rate of 15%, a reduction to 7% will require a sample size of 239 patients per group to achieve statistically significance (Chi-squared test, alpha 0.05, beta 0.80).

Regarding the prospective cohort, interims analysis will be performed after each 10 TAVR procedures. In case a signal towards worse outcomes with the modified implantation technique will be observed, the institutional safety and endpoint adjudication committee will stop further execution of the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients referred to TAVR procedure due to severe aortic stenosis

Exclusion criteria

  • PM-implantation before TAVR
  • Valve-in-valve procedures

Treatment and study plan

TAVR

Procedure

TAVR implantation in cusp overlay technique

Primary outcomes

  1. Pacemaker implantation rate

    Time frame: Day 5 after TAVR

    Primary endpoint

Secondary outcomes

  1. Extent of paravalvular leak

    Time frame: Day 5 after TAVR

    Secondary endpoint

  2. Number of patients alive

    Time frame: 30 days

    Secondary endpoint

Sponsors and collaborators

Lead sponsor

University of Ulm

Other

Registry information

Acronym: MIDAS - ULM

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Feb 2, 2021
Registry last updated
Nov 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.